BPaL/M is a six-month all-oral regimen recommended by the World Health Organization (WHO) to treat most forms of ...

Screening for both active and dormant tuberculosis (TB) infections simultaneously could enhance detection and improve ...

Has the recent Tuberculosis outbreak in Kansas got you worried about catching TB? Learn about the top symptoms to look out ...

Researchers hope this new approach, published in the European Respiratory Journal, will inform guidance from global health ...

A pioneering study presented today at ESCMID Global 2025 has demonstrated that an AI-powered lung ultrasound outperforms ...

A new strategy for tuberculosis (TB) screening, proposed by a team of researchers led by Queen Mary University of London, ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators ...

A new strategy for tuberculosis (TB) screening provides a solution to problems with current TB screening, which does not always accurately detect disease. Simultaneously screening for both active and ...

Acknowledging India’s contribution to TB vaccine research, Dr. Swaminathan noted that the overall TB vaccine pipeline remains ...

Tuberculosis (TB) is an infectious disease that kills more than a million people worldwide every year. The pathogen that ...

Learn how new TB treatments show higher success rates and fewer side effects with shorter, all-oral regimens. Discover more.

In a lab in the heart of Boston, professor Bree Aldridge leads a team of researchers trying to understand a threat that is ...